Unusual suspects of secondary diabetes and growth retardation: Bartter and Gitelman syndrome
Abstract
Bartter syndrome and Gitelman syndrome are rare autosomal recessive syndromes. In extremely rare cases, GS may diagnosed with growth retardation and diabetes mellitus. In this 3-case series, growth retardation was identified at 17-year follow-up of our dizygotic twin patients diagnosed with BS and glucose metabolism disorder was developed. Whereas, 3RD. patient diagnosed with GS in adulthood period developed diabetes mellitus after 8 years follow up. Chronic hypopotassemia has been shown to cause diabetes mellitus and growth retardation ın several articles. Potassium plays an important role in insulin, IGF-1 and growth hormone cycle. Herein, we aimed to draw attention to that, the presence of chronic hypopotassemia may precipitate to diseases such as growth retardation and diabetes mellitus over time.
Keywords
References
- 4) Bettinelli A, Bianchetti MG, Girardin E, et al. Use of calcıum excretion values tı distinguish two forms of primary renal tubuler hypokalemic alkalosis: Bartter and Gitelman syndromes. J Pediatr 1992; 120:38.
- 5) Cruz DN, Shaer AJ, Bia MJ, et al. Gitelman’s syndrome revisited: an evaluation of symptoms and health related quality of life. Kıdney Int 2001;59:710.
- 6) Cruz DN, Simon DB, Nelson-Williams C, et al. Mutations in the Na-Cl cotransporter reduce blood pressure in humans. Hypertension 2001; 37:1458.
- 8) Sann L, David L, Bernheim J, François R. Hypophosphatemia and hyperparathyroidism in a case of Bartter’s syndrome. Helv Pediatr Acta 1978; 33:299
- 9) Bettinelli A, Vigano C, Provero MC, et al. Phosphate homeostasis in Bartter syndrome: a case-control study. Pediatr Nephrol 2014; 29:2133.
- 10) Riveira-Munoz E, Chang Q, Godefroid N, et al. Transcriptional and functional analyses of SLC12A3 mutations: new ckues for the pathogenesis of Gitelman syndrome. J Am Soc Nephrol 2007; 18:1271.
- 1) Flyvbjerg A, Dorup I, Everts ME, Orskow H. Evidence that potassium deficiency induces growth retardation through reduced circulating levels of growth hormone ad insulin like growth factor I. Metabolism 1991;40:769-75.
- 2) Gil-Pena H, Garcia-Lopez E, Alvares-Garcia O, Loredo V, Carbajo-Perez E, Ordonez FA, et al. Alterations of growth plate and abnormal insulin-like growth factor I metabolism in growth hormone treatment. Am J Physiol Renal Phsiol 2009;297:F639-45.
Details
Primary Language
English
Subjects
Health Care Administration
Journal Section
Case Report
Authors
Zeynel Abidin Sayiner
Gaziantep University, Faculty of Medicine, Department of Endocrinology&Metabolism, Gaziantep, Turkey
Türkiye
Burak Okyar
This is me
GAZIANTEP UNIVERSITY, FACULTY OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE
Türkiye
Ayten Eraydin
This is me
Gaziantep University, Faculty of Medicine, Department of Endocrinology&Metabolism, Gaziantep, Turkey
Türkiye
Mesut Ozkaya
This is me
Gaziantep Dr. Ersin Arslan Research Hospital, Dept. of Endocrinology&Metabolism Gaziantep, TR
Türkiye
Publication Date
February 28, 2017
Submission Date
February 15, 2017
Acceptance Date
February 24, 2017
Published in Issue
Year 2017 Volume: 4 Number: 2